Dendritic cell delivery of plasmid DNA: Applications for controlled genetic immunization

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 19, Issue 1, 2001, Pages 79-95

  Mumper, Russell J ^a   Ledebur, Harry C ^b  

^a University of Kentucky   (United States)

^b Caprion Pharmaceuticals   (Canada)

Author keywords

Colloid; Gene gun; Jet injection; Plasmid DNA; Skin; Vaccines

Indexed keywords

HEPATITIS B VACCINE; PLASMID DNA; VACCINE;

ANTIGEN PRESENTING CELL; DENDRITIC CELL; DRUG DELIVERY SYSTEM; GENE EXPRESSION; GENE GUN; GENE TRANSFER; IMMUNE RESPONSE; IMMUNIZATION; LANGERHANS CELL; REVIEW;

ANIMALS; DENDRITIC CELLS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HUMANS; PLASMIDS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0034793025     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:19:1:079     Document Type: Review

References (117)

1. Genetic immunization is a simple method for eliciting an immune response
2. DNA Vaccines: A new Era in Vaccinology
3. DNA vaccines
4. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene
5. Cancer gene therapy using plasmid DNA: Safety evaluation in rodents and non-human primates
6. Direct gene transfer into nonhuman primate myofibers in vivo
7. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates
8. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells
9. Gene vaccination with naked plasmid DNA: Mechanism of CTL priming
10. Role of bone marrow derived cells in presenting MHC class I-restricted tumor antigens
11. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells
12. In vivo priming by DNA injection occurs predominantly by antigen transfer
13. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations
14. Determination of tissue distribution of an intramuscular plasmid vaccine using PCR and in situ DNA hybridization
15. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice
16. The dendritic cell system and its role in immunogenicity
17. Cloned dendritic cells can present exogenous antigens on both class I and class II molecules
18. Characterization of plasmid DNA transfer into mouse skeletal muscle: Evaluation of uptake mechanism, expression and secretion of gene products into blood
19. Gene therapy by intramuscular injection of plasmid DNA: Studies on firely luciferase gene expression in mice
20. Expression of naked plasmids by cultured mytotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle
21. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle
22. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle
23. Protective interactive non-condensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle
24. Polymeric gene delivery systems for in vivo gene therapy
25. Expression of biologically active human insulin-like growth factor-I following intramuscular injection of a formulated plasmid in rats
26. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
27. Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response
28. Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity
29. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma
30. Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines
31. DNA-based immunization by in vivo transfection of dendritic cells
32. Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses
33. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization
34. Immunological properties of gene vaccines delivered by different routes
35. Targeting the skin for genetic immunization
36. Intradermal DNA immunization by using jet-injectors in mice and monkeys
37. DNA-based non-invasive vaccination onto the skin
38. Immunization via hair follicles by topical application of naked DNA to normal skin
39. Liposome-mediated DNA vaccination
40. Mechanism of liposome adjuvanticity: An in vivo approach
41. The immunological adjuvant and vaccine carrier properties of liposomes
42. Liposomes as immunoadjuvants and vaccine carriers: Antigen entrapment
43. Transferrin-polycation conjugates as carriers for DNA uptake into cells
44. Folate receptor mediated DNA delivery into tumor cells: Protosomal disruption results in enhanced gene expression
45. Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T-cell receptor complex
46. Receptor-mediated gene delivery in vivo
47. Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells
48. Glycosylated polylysine/DNA complexes: Gene transfer efficiency in relation with the size and the sugar substitution level of a glycosylated polylysines and with the plasmid size
49. Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages
50. Receptor-mediated gene transfer into macrophages
51. Transloading of tumor antigen-derived peptides into antigen-presenting cells
52. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells
53. Pharmaceutical approach to somatic gene therapy
54. Controllable gene therapy: Recent advances in non-viral gene delivery, in targeting of drugs 5
55. Induction of mucosal anti-HIV antibodies by facilitated transfection of airway epithelium with lipospermine/DNA complexes
56. Efficacy of a peptide-based gene delivery system depends on mitotic activity
57. Lipophilic polylysines mediate efficient DNA transfection in mammalian cells
58. Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries
59. Gene therapy in the United States: A five-year status report
60. Nasal application of the cationic liposome DC-Chol: DOPE does not alter ion transport, lung function or bacterial growth
61. Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma
62. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans
63. Chimerasome-mediated gene transfer in vitro and in vivo
64. Antigen cochleate preparations for oral and systemic vaccination
65. Emulsion formulations as a vector for gene delivery in vitro and in vivo
66. Effect of non-ionic surfactants on the formation of DNA/emulsion complexes and emulsion-mediated gene transfer
67. New cationic lipid formulations for gene transfer
68. Targeted delivery of DNA by liposomes and polymers
69. Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes
70. Cationic lipid enhances in vitro receptor-mediated transfection
71. Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes
72. Receptor-mediated gene transfer into hepatic cells using asialoglycoprotein-labeled liposomes
73. Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin
74. Biologically active, recombinant DNA in clathrincoated vesicles isolated from rat livers after in vivo injection of liposome-encapsulated DNA
75. The mannose receptor and other macrophage lectins
76. Neo-mannosylated liposomes: Synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages
77. Preparation and characterization of liposomes containing mannosylated phospholipid capable of targetting drugs to macrophages
78. Use of mannosylated liposomes for in vivo targeting of a macrophage activator and control of artificial pulmonary metastases
79. Macrophage activation by MDP bound to neoglycoproteins: Metastasis eradication in mice
80. Phospholipid vesicle targeting using synthetic glycolipid and other determinants
81. Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats
82. Advanced colloid-based systems for efficient delivery of drugs and diagnostic agents to the lymphatic tissue
83. Lymph nodes localization of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers
84. Drug delivery to lymphatic tissue
85. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes
86. Liposomes as adjuvants for vaccines
87. Novel polymeric condensing carriers for gene delivery
88. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery
89. Chitosan as a novel nasal delivery system for peptide drugs
90. Controlled release of indomethacin by chitosan-polyelectrolyte complex: Optimization and in vivo/in vitro evaluation
91. Effect of interpolymer complex formation of chitosan with pectin or acacia on the release behavior of chlorpromazine HCl
92. Fixation of 5-fluorouracil to chitosan and its antitumor activity
93. Adriamycin analogues: Preparation and antitumor evaluation
94. Lysozyme degradation of partially deacetylated chitin, its films and hydrogels
95. Biocompatibility of chitosan by oral and intravenous administration
96. The mannose receptor and other macrophage lectins
97. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy
98. Induction of antibodies to a k V region by gene immunization
99. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines
100. Selected strategies to augment polynucleotide immunization
101. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12
102. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids
103. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes
104. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice
105. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractivecDNA cloning
106. Induction of Th2-directed immune responses by IL-4-transduced dendritic cells in mice
107. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily
108. Dendritic cells in the T-cell areas of lymphoid organs
109. Internal initiation of translation in eukaryotes: The picornavirus paradigm and beyond
110. Cis-acting elements of the encephalomyocarditis virus internal ribosomal entry site
111. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12
112. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: In vitro and in vivo production of biologically active interleukin-12
113. Effective eradication of established murine tumors with IL-12 gene therapy using a poylcistronic retroviral vector